drugset / Trial / NCT01219049

L-Tyrosine Supplementation in Patients With Fibromyalgia

NCT01219049

RandomizedParallel-groupDouble-blindTreatment

Summary

Patients in the study, who have a diagnosis of fibromyalgia, will be randomly assigned to take the amino acid L-tyrosine or placebo (blank pill) for 3 weeks. They will fill out questionnaires about their symptoms and see if they have any improvement. The investigators hypothesis is that taking tyrosine will help alleviate the symptoms of fibromyalgia.

Timeline

Start
2010-01
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject tyrosine Unknown 1000 mg
Subject tyrosine Unknown 2000 mg

Indications